54.35
price up icon11.97%   5.81
after-market Dopo l'orario di chiusura: 56.32 1.97 +3.62%
loading
Precedente Chiudi:
$48.54
Aprire:
$49
Volume 24 ore:
20.76M
Relative Volume:
2.58
Capitalizzazione di mercato:
$21.57B
Reddito:
$2.23B
Utile/perdita netta:
$-3.19B
Rapporto P/E:
-6.6718
EPS:
-8.1462
Flusso di cassa netto:
$-1.60B
1 W Prestazione:
+19.79%
1M Prestazione:
+4.32%
6M Prestazione:
+121.48%
1 anno Prestazione:
+122.93%
Intervallo 1D:
Value
$48.98
$57.78
Intervallo di 1 settimana:
Value
$45.29
$57.78
Portata 52W:
Value
$22.28
$59.55

Moderna Inc Stock (MRNA) Company Profile

Name
Nome
Moderna Inc
Name
Telefono
(617) 714-6500
Name
Indirizzo
325 BINNEY STREET, CAMBRIDGE
Name
Dipendente
4,700
Name
Cinguettio
@moderna_tx
Name
Prossima data di guadagno
2026-05-01
Name
Ultimi documenti SEC
Name
MRNA's Discussions on Twitter

Compare MRNA vs VRTX, REGN, ARGX, ALNY, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
MRNA icon
MRNA
Moderna Inc
54.35 19.26B 2.23B -3.19B -1.60B -8.1462
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
429.82 107.87B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
714.89 74.34B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
782.17 48.96B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
295.05 39.51B 4.29B 577.22M 641.34M 4.2086
ONC icon
ONC
Beone Medicines Ltd Adr
312.12 32.89B 5.36B 287.73M 924.18M 2.5229

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-01-28 Ripresa Barclays Equal Weight
2026-01-07 Ripresa UBS Neutral
2025-12-12 Iniziato Jefferies Hold
2025-03-13 Iniziato Citigroup Neutral
2025-02-18 Downgrade Barclays Overweight → Equal Weight
2025-01-29 Downgrade Goldman Buy → Neutral
2024-12-18 Downgrade Argus Buy → Hold
2024-12-10 Ripresa BofA Securities Underperform
2024-11-19 Iniziato Berenberg Hold
2024-11-18 Aggiornamento HSBC Securities Hold → Buy
2024-11-15 Iniziato Wolfe Research Underperform
2024-10-17 Iniziato Bernstein Mkt Perform
2024-09-13 Downgrade JP Morgan Neutral → Underweight
2024-09-13 Downgrade Jefferies Buy → Hold
2024-09-13 Downgrade Oppenheimer Outperform → Perform
2024-08-28 Aggiornamento HSBC Securities Reduce → Hold
2024-08-07 Aggiornamento Deutsche Bank Sell → Hold
2024-08-05 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Downgrade HSBC Securities Hold → Reduce
2024-01-02 Aggiornamento Oppenheimer Perform → Outperform
2023-11-29 Iniziato Canaccord Genuity Hold
2023-11-03 Aggiornamento HSBC Securities Reduce → Hold
2023-11-02 Downgrade Deutsche Bank Hold → Sell
2023-08-04 Downgrade TD Cowen Outperform → Market Perform
2023-08-03 Downgrade Deutsche Bank Buy → Hold
2023-07-24 Iniziato William Blair Mkt Perform
2023-07-14 Iniziato HSBC Securities Reduce
2023-06-26 Aggiornamento UBS Neutral → Buy
2023-04-26 Iniziato Guggenheim Neutral
2023-03-13 Aggiornamento TD Cowen Market Perform → Outperform
2023-03-02 Iniziato RBC Capital Mkts Outperform
2023-02-24 Downgrade SVB Securities Market Perform → Underperform
2022-12-19 Aggiornamento Jefferies Hold → Buy
2022-12-14 Downgrade Chardan Capital Markets Buy → Neutral
2022-10-21 Aggiornamento SVB Leerink Underperform → Mkt Perform
2022-09-08 Aggiornamento Deutsche Bank Hold → Buy
2022-02-01 Aggiornamento Redburn Sell → Neutral
2022-01-26 Aggiornamento Deutsche Bank Sell → Hold
2022-01-21 Aggiornamento BofA Securities Underperform → Neutral
2022-01-21 Iniziato UBS Neutral
2021-12-07 Iniziato Cowen Market Perform
2021-11-09 Iniziato Wolfe Research Outperform
2021-10-22 Iniziato Deutsche Bank Sell
2021-10-15 Aggiornamento Piper Sandler Neutral → Overweight
2021-08-06 Downgrade Oppenheimer Outperform → Perform
2021-08-06 Downgrade Piper Sandler Overweight → Neutral
2021-07-15 Reiterato Jefferies Hold
2021-02-01 Downgrade BofA Securities Neutral → Underperform
2020-12-16 Downgrade Jefferies Buy → Hold
2020-12-16 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-12-09 Downgrade Needham Buy → Hold
2020-11-23 Iniziato Wells Fargo Equal Weight
2020-11-17 Downgrade BMO Capital Markets Outperform → Market Perform
2020-09-08 Downgrade SVB Leerink Mkt Perform → Underperform
2020-07-23 Iniziato SVB Leerink Mkt Perform
2020-07-20 Downgrade JP Morgan Overweight → Neutral
2020-07-13 Iniziato Jefferies Buy
2020-06-30 Iniziato Argus Buy
2020-06-08 Iniziato Barclays Overweight
2020-04-30 Iniziato BMO Capital Markets Outperform
2020-03-05 Downgrade BofA/Merrill Buy → Neutral
2019-12-03 Ripresa BofA/Merrill Buy
2019-10-25 Iniziato ROTH Capital Buy
2019-04-05 Iniziato Chardan Capital Markets Buy
Mostra tutto

Moderna Inc Borsa (MRNA) Ultime notizie

pulisher
May 08, 2026

MRNA stock clocks best day in over two months on early-stage hantavirus vaccine research - MSN

May 08, 2026
pulisher
May 08, 2026

MRNA Stock Clocks Best Day In Over Two Months On Early-Stage Hantavirus Vaccine Research - Stocktwits

May 08, 2026
pulisher
May 08, 2026

[Form 4] Moderna, Inc. Insider Trading Activity - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Moderna (MRNA) Gains Attention Amid Rising Virus Concerns - GuruFocus

May 08, 2026
pulisher
May 08, 2026

MRNA Stock Alert: Moderna Surges on Hantavirus Vaccine Hopes - Yahoo Finance

May 08, 2026
pulisher
May 08, 2026

Moderna (MRNA) Shares Skyrocket, What You Need To Know - TradingView

May 08, 2026
pulisher
May 08, 2026

Moderna Stock Surges on Hantavirus Vaccine News as Cruise Outbreak Puts mRNA Pipeline Back in Focus - TechStock²

May 08, 2026
pulisher
May 08, 2026

Moderna (MRNA) Advances Hantavirus Vaccine Development Amid Rene - GuruFocus

May 08, 2026
pulisher
May 08, 2026

Moderna Accelerates Hantavirus Vaccine Research Amid Cruise Outbreak - AsatuNews.co.id

May 08, 2026
pulisher
May 08, 2026

How Hantavirus Made Moderna a Must-Own Stock Again - Barron's

May 08, 2026
pulisher
May 08, 2026

Top Biotech Stocks To Follow NowMay 8th - MarketBeat

May 08, 2026
pulisher
May 08, 2026

What's Going On With Novavax Stock On Friday?Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX) - Benzinga

May 08, 2026
pulisher
May 08, 2026

Moderna flags work on hantavirus vaccines before cruise outbreak - The Boston Globe

May 08, 2026
pulisher
May 08, 2026

Moderna jumps on word it is working on a hantavirus vaccine - Seeking Alpha

May 08, 2026
pulisher
May 08, 2026

Moderna (NASDAQ:MRNA) Trading 12.6% HigherShould You Buy? - MarketBeat

May 08, 2026
pulisher
May 08, 2026

Moderna (MRNA) Stock Surges 16% on Flu Vaccine Data and Analyst Upgrades - CoinCentral

May 08, 2026
pulisher
May 08, 2026

Moderna stock surges on hantavirus vaccine research confirmation - Investing.com

May 08, 2026
pulisher
May 08, 2026

Moderna Flags Work on Hantavirus Vaccines Before Cruise Outbreak - Bloomberg

May 08, 2026
pulisher
May 08, 2026

[144] Moderna, Inc. SEC Filing - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Why is Moderna stock surging today? By Investing.com - Investing.com Canada

May 08, 2026
pulisher
May 08, 2026

Moderna Stock Rises On Positive Phase 3 Flu Data: What Investors Need To Know - Benzinga

May 08, 2026
pulisher
May 08, 2026

Moderna Stock Climbs After Hantavirus Vaccine: Data Triggers Analyst Price Target - Investing.com

May 08, 2026
pulisher
May 08, 2026

Moderna Inc. stock (US60770K1034): Shares rebound after earnings and strong 2026 run-up - AD HOC NEWS

May 08, 2026
pulisher
May 08, 2026

Moderna Stock Climbs After Hantavirus Vaccine: Data Triggers Analyst Price Target Hikes - Tokenist

May 08, 2026
pulisher
May 08, 2026

CHINA SHOTO : 9000 Leverage Shares 3x Long Moderna (MRNA) ETP Securities - marketscreener.com

May 08, 2026
pulisher
May 08, 2026

Gateway Investment Advisers LLC Acquires 131,364 Shares of Moderna, Inc. $MRNA - MarketBeat

May 08, 2026
pulisher
May 08, 2026

5 Insightful Analyst Questions From Moderna’s Q1 Earnings Call - The Globe and Mail

May 08, 2026
pulisher
May 07, 2026

Moderna (MRNA) Stock Surges on Hantavirus Outbreak News, Analysts Warn of Speculation - GuruFocus

May 07, 2026
pulisher
May 07, 2026

MRNA Stock Quote Price and Forecast - CNN

May 07, 2026
pulisher
May 07, 2026

Hantavirus: What to Know About the Virus—and Why Moderna Stock Rallied - Barron's

May 07, 2026
pulisher
May 07, 2026

Investors Buy Large Volume of Moderna Call Options (NASDAQ:MRNA) - MarketBeat

May 07, 2026
pulisher
May 07, 2026

Moderna Stock Rallied on Hantavirus Fears. What to Know. - Barron's

May 07, 2026
pulisher
May 07, 2026

Moderna stock holds steady amid regulatory review of mRNA-1010 in US, EU, Canada, Australia - Traders Union

May 07, 2026
pulisher
May 07, 2026

Moderna stock jumps 10% amid hantavirus outbreak concerns By Investing.com - Investing.com Canada

May 07, 2026
pulisher
May 07, 2026

Brookline Capital Markets Forecasts Moderna FY2026 Earnings - MarketBeat

May 07, 2026
pulisher
May 07, 2026

NVAX Stock Eyes Breakout Week: Novavax Claims Patients Were ‘Twice As Likely’ To Pick Its COVID Shot Over Moderna Again - Stocktwits

May 07, 2026
pulisher
May 06, 2026

MRNA SEC FilingsModerna 10-K, 10-Q, 8-K Forms - Stock Titan

May 06, 2026
pulisher
May 06, 2026

Moderna Shareholders OK Directors, Executive Pay Votes and Ernst & Young as 2026 Auditor at AGM - Yahoo Finance

May 06, 2026
pulisher
May 06, 2026

Is Wall Street Bullish or Bearish on Moderna Stock? - Yahoo Finance

May 06, 2026
pulisher
May 06, 2026

Moderna flu vaccine shows superior efficacy in phase 3 study By Investing.com - Investing.com Australia

May 06, 2026
pulisher
May 06, 2026

Moderna flu vaccine shows superior efficacy in phase 3 study - Investing.com

May 06, 2026
pulisher
May 06, 2026

Moderna's flu shot heads to FDA decision after NEJM Phase 3 data - Stock Titan

May 06, 2026
pulisher
May 06, 2026

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010 - Weatherford Democrat

May 06, 2026
pulisher
May 06, 2026

Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial - Reuters

May 06, 2026
pulisher
May 06, 2026

Moderna's mRNA flu vaccine is more effective than the standard shot in a late-stage trial - AOL.com

May 06, 2026
pulisher
May 06, 2026

MRNA Stock Price, Quote & Chart | MODERNA INC (NASDAQ:MRNA) - ChartMill

May 06, 2026
pulisher
May 05, 2026

Moderna stands as the best performing large-cap healthcare stock YTD - MSN

May 05, 2026
pulisher
May 05, 2026

FDA halts publication of studies on COVID, shingles vaccines - Seeking Alpha

May 05, 2026
pulisher
May 05, 2026

Brookline Capital Markets Weighs in on Moderna Q2 Earnings - MarketBeat

May 05, 2026
pulisher
May 05, 2026

Non-covid mRNA Vaccine and Therapeutics Market Supply Chain Analysis and Revenue Forecast 2026 to 2035 - openPR.com

May 05, 2026
pulisher
May 05, 2026

Moderna (MRNA) Receives a Buy from Piper Sandler - The Globe and Mail

May 05, 2026

Moderna Inc Azioni (MRNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$101.35
price down icon 3.48%
$50.79
price up icon 1.18%
$94.12
price up icon 1.19%
$141.81
price down icon 0.49%
ONC ONC
$312.12
price down icon 1.54%
Capitalizzazione:     |  Volume (24 ore):